Gemina Laboratories Ltd.
GLAB
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -240.60K | -301.20K | -535.30K | -999.80K | -629.10K |
| Total Depreciation and Amortization | 1.90K | 2.00K | 20.70K | 21.20K | 21.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.00K | -4.60K | 66.60K | 197.00K | 81.80K |
| Change in Net Operating Assets | 261.60K | 282.40K | 470.00K | 756.40K | 396.80K |
| Cash from Operations | 24.90K | -21.40K | 22.00K | -25.20K | -129.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 13.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 13.00K | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | 50.00K |
| Total Debt Repaid | -35.30K | 0.00 | -10.40K | -31.20K | -31.50K |
| Issuance of Common Stock | 0.00 | 0.00 | 8.00K | 1.60K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.50K | 0.00 | -14.50K | 6.10K | -6.10K |
| Cash from Financing | -15.00K | 0.00 | -11.90K | -16.50K | 8.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | -- |
| Net Change in Cash | 10.00K | -21.40K | 10.00K | -28.80K | -121.00K |